Scarica l'app Stockscreener
23.06
5.88%
1.28
Dopo l'orario di chiusura:
23.17
0.11
+0.48%
Precedente Chiudi:
$21.78
Aprire:
$21.95
Volume 24 ore:
1.45M
Relative Volume:
1.28
Capitalizzazione di mercato:
$1.98B
Reddito:
$1.13B
Utile/perdita netta:
$62.75M
Rapporto P/E:
36.60
EPS:
0.63
Flusso di cassa netto:
$170.92M
1 W Prestazione:
-1.83%
1M Prestazione:
-0.65%
6M Prestazione:
+5.06%
1 anno Prestazione:
+6.76%
Intervallo 1D:
$21.71
$23.20
Intervallo di 1 settimana:
$21.26
$26.38
Portata 52W:
$13.39
$26.76
Progyny Inc Stock (PGNY) Company Profile
Nome
Progyny Inc
Settore
Industria
Telefono
212-888-3124
Indirizzo
1359 BROADWAY, NEW YORK, NY
Confronta PGNY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
23.06 | 1.87B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
271.81 | 228.94B | 422.82B | 21.30B | 25.27B | 23.08 |
|
CVS
Cvs Health Corp
|
65.90 | 82.29B | 386.64B | 4.53B | 4.78B | 3.58 |
|
CI
Cigna Group
|
287.10 | 73.95B | 260.93B | 5.02B | 3.94B | 18.32 |
|
ELV
Elevance Health Inc
|
294.43 | 65.48B | 189.25B | 5.36B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
281.99 | 32.07B | 117.76B | 1.21B | 2.39B | 9.95 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-08 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-12-02 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-11-13 | Downgrade | Truist | Buy → Hold |
| 2024-09-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-08-07 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-05-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-09-27 | Iniziato | Canaccord Genuity | Buy |
| 2023-05-22 | Iniziato | BTIG Research | Buy |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-05 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | Iniziato | Truist | Buy |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-11-22 | Downgrade | Citigroup | Buy → Neutral |
| 2021-09-30 | Iniziato | Berenberg | Buy |
| 2021-08-12 | Iniziato | Barclays | Overweight |
| 2021-06-02 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-04-29 | Ripresa | JP Morgan | Overweight |
| 2021-03-10 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-07-01 | Iniziato | SVB Leerink | Outperform |
| 2020-06-02 | Iniziato | Guggenheim | Buy |
| 2019-11-19 | Iniziato | Citigroup | Buy |
| 2019-11-19 | Iniziato | Goldman | Buy |
| 2019-11-19 | Iniziato | JP Morgan | Overweight |
| 2019-11-19 | Iniziato | Piper Jaffray | Overweight |
| 2019-11-19 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Progyny Inc Borsa (PGNY) Ultime notizie
Progyny’s Earnings Call Highlights Robust Growth and Strategic Partnerships - MSN
Progyny raises full-year 2025 revenue guidance to $1.27B as member engagement and product expansion accelerate - MSN
PGNY Q2 Deep Dive: Product Expansion and Client Diversification Drive Upbeat Guidance - TradingView
Progyny Exceeds Earnings Expectations, Analysts Expect Continued Growth in 2025 - AInvest
Progyny's Q2 2025 Earnings Call: Unpacking Contradictions in Sales Performance, Pricing Impact, and Margin Expectations - AInvest
Progyny, Inc. Just Beat EPS By 12%: Here's What Analysts Think Will Happen Next - ca.finance.yahoo.com
Price momentum metrics for Progyny Inc. explainedFree Breakout Momentum Picks With Protection - Newser
What makes Progyny Inc. stock price move sharplyTechnical Long-Term Outlook and Recap Guide - Newser
Using R and stats models for Progyny Inc. forecastingChart Based Entry Tool for ROI Traders - Newser
Why Progyny Inc. stock attracts strong analyst attentionFuture Growth Stock Forecasting Strategy - Newser
Is Progyny Inc. a defensive stockFast Payout Trading Plans - newsyoung.net
A Quick Look at Today's Ratings for Progyny(PGNY.US), With a Forecast Between $28 to $30 - 富途牛牛
Progyny, Inc. (NASDAQ:PGNY) Q2 2025 Earnings Call Transcript - Insider Monkey
Advanced analytics toolkit walkthrough for Progyny Inc.Trading Volume Anomaly Summary and Insight - Newser
Progyny 2025 Q2 Earnings Net Income Grows 3.8% Despite Stock Sell-Off - AInvest
Can Progyny Inc. deliver consistent dividendsWealth Catalysts in Stocks - thegnnews.com
Progyny (NASDAQ:PGNY) Shares Gap Up After Analyst Upgrade - Defense World
PGNY News Today | Why did Progyny stock go down today? - MarketBeat
Progyny Outpaces Expectations And Lifts 2025 Outlook - Finimize
Cantor Fitzgerald reiterates Overweight rating on Progyny stock By Investing.com - Investing.com South Africa
Strong Financial Performance and Market Trends Support Buy Rating for Progyny - TipRanks
Progyny, Inc. SEC 10-Q Report - TradingView
Earnings call transcript: Progyny Q2 2025 beats EPS forecasts with strong growth - Investing.com
Progyny's Q2 Adjusted Earnings, Revenue Increase; 2025 Outlook Raised - MarketScreener
Zurcher Kantonalbank Zurich Cantonalbank Has $507,000 Holdings in Progyny, Inc. (NASDAQ:PGNY) - Defense World
Progyny Inc (PGNY) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Partnerships ... - Yahoo Finance
Progyny, Inc. Reports Record Q2 2025 Revenue - TipRanks
Transcript : Progyny, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Progyny (PGNY) Tops Q2 Earnings and Revenue Estimates - Yahoo Finance
Progyny's Q2 2024 Earnings: A Strategic Buy Opportunity Amid Strong EBITDA Growth and Aggressive Buybacks - AInvest
Progyny earnings beat by $0.32, revenue topped estimates - Investing.com Canada
Progyny: Q2 Earnings Snapshot - Erie News Now
Progyny reports Q2 adjusted EPS 48c, consensus 43c - TipRanks
Progyny (NASDAQ:PGNY) Beats Expectations in Strong Q2, Full-Year Sales Guidance is Optimistic - TradingView
(PGNY) Progyny, Inc. Expects Q3 Revenue Range $290.0M$305.0M - MarketScreener
(PGNY) Progyny, Inc. Expects Q3 Adjusted EPS Range $0.37$0.40 - MarketScreener
Earnings Flash (PGNY) Progyny, Inc. Reports Q2 Revenue $332.9M, vs. FactSet Est of $320.1M - MarketScreener
Earnings Flash (PGNY) Progyny, Inc. Posts Q2 Adjusted EPS $0.48 per Share, vs. FactSet Est of $0.16 - MarketScreener
Progyny, Inc. Announces Second Quarter 2025 Results - Yahoo Finance
Progyny Earnings Report: Insights and ExpectationsNews and Statistics - IndexBox
Progyny Earnings: What To Look For From PGNY - Yahoo Finance
Three Low-Volatility Stocks to Reconsider: J.M. Smucker, Sherwin-Williams, and Progyny. - AInvest
Is Progyny Inc. a growth stock or a value stockGet daily updates on promising stocks - Jammu Links News
Is Progyny Inc. stock overvalued or undervaluedCapitalize on market momentum for big wins - Jammu Links News
What are the latest earnings results for Progyny Inc.Unlock powerful portfolio optimization tools - Jammu Links News
What catalysts could drive Progyny Inc. stock higher in 2025High-octane gains - Jammu Links News
What is the dividend policy of Progyny Inc. stockRapid portfolio appreciation - Jammu Links News
Does Progyny Inc. stock perform well during market downturnsBreakout stock performance - Jammu Links News
What analysts say about Progyny Inc. stockPhenomenal wealth increase - Jammu Links News
How does Progyny Inc. generate profit in a changing economyRobust investment performance - Jammu Links News
What is Progyny Inc. company’s growth strategyAchieve unparalleled market performance - Jammu Links News
Progyny Inc Azioni (PGNY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.75%
0.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):